Wai Yuen Tong Medicine Holdings Limited

897 BMG9421Y2332

Pharmaceuticals

Market Closed - Hong Kong S.E. Other stock markets 04:08:42 2024-06-28 EDT			5-day change	1st Jan Change
0.33 ^HKD	-1.49%		+53.49%	-17.50%

06-27	Wai Yuen Tong Medicine's Losses Shrink in Fiscal Year 2024; Shares Surge 34%	MT
06-27	Wai Yuen Tong Medicine Holdings Limited Proposes Special Dividend, Payable on 06 September 2024	CI

Wai Yuen Tong Medicine Holdings Limited Proposes Final Dividend for the Year Ended March 31, 2024, Payable on 06 September 2024

June 26, 2024 at 07:40 pm

Wai Yuen Tong Medicine Holdings Limited proposed a final dividend of HKD 0.03 per share for the year ended March 31, 2024. Date of shareholders' approval 20 August 2024. The ex-dividend date on 22 August 2024.

The record date is on 26 August 2024. The payment date is on 06 September 2024.

Latest news about Wai Yuen Tong Medicine Holdings Limited

Wai Yuen Tong Medicine's Losses Shrink in Fiscal Year 2024; Shares Surge 34%	06-27	MT
Wai Yuen Tong Medicine Holdings Limited Proposes Special Dividend, Payable on 06 September 2024	06-26	CI
Wai Yuen Tong Medicine Holdings Limited Proposes Final Dividend for the Year Ended March 31, 2024, Payable on 06 September 2024	06-26	CI
Wai Yuen Tong Medicine Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2024	06-26	CI
Wai Yuen Tong Medicine Holdings Limited commences an Equity Buyback Plan for 117,110,288 shares, representing 10% of its issued share capital, under the authorization approved on August 22, 2023.	04-02	CI
Wai Yuen Tong Medicine Holdings Limited Announces Changes of Company Secretary, with Effect from 1 April 2024	03-28	CI
Wai Yuen Tong Medicine Unit to Sell Properties in Hong Kong	03-04	MT
Wai Yuen Tong Medicine Plans Special Dividend of Wang On, China Agri-Products Shares; Shares Up 7%	01-26	MT
Wai Yuen Tong Medicine Holdings Limited agreed to Spin-Off Wang On Group Limited.	01-24	CI
Wai Yuen Tong to Buy Shop Space in Hong Kong	01-23	MT
Wai Yuen Tong Medicine Shareholders to Vote Jan. 30 on Granting of Loan Facility to Wang On	01-10	MT
Tranche Update on Wai Yuen Tong Medicine Holdings Limited's Equity Buyback Plan announced on September 1, 2022.	12-21	CI
Wai Yuen Tong Medicine to Extend Revolving Loan Facility to Wang On	12-18	MT
Wai Yuen Tong Medicine Holdings Limited Announces Change of Independent Non-Executive Directors and Change in Compositions of Board Committees	12-08	CI
Wai Yuen Tong Medicine Returns to Profit in Fiscal H1	11-28	MT
Wai Yuen Tong Medicine Holdings Limited Reports Earnings Results for the Half Year Ended September 30, 2023	11-28	CI
Wai Yuen Tong Medicine Subsidiary Sells Stake in Owner of Leased Shops	11-21	MT
Wai Yuen Tong Medicine to Return to Profit in Fiscal H1	11-14	MT
Wai Yuen Tong Medicine Holdings Limited Provides Consolidated Earnings Guidance for the Six Months Ended 30 September 2023	11-13	CI
Wai Yuen Tong Medicine Holdings Limited's Equity Buyback announced on September 1, 2022, has expired with 60,540,000 shares, representing 4.98% for HKD 24.69 million.	23-08-21	CI
Wai Yuen Tong Medicines' Fiscal Year 2023 Loss Narrows	23-06-29	MT
Tranche Update on Wai Yuen Tong Medicine Holdings Limited's Equity Buyback Plan announced on September 1, 2022.	23-06-28	CI
Wai Yuen Tong Medicine Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-06-28	CI
Lei Wa entered completed the acquisition of Billion Good Investment Limited from Wai Yuen Tong Medicine Holdings Limited and Wang On Limited.	23-06-18	CI
Wai Yuen Tong Medicine to Narrow Full-Year Loss	23-06-09	MT

Chart Wai Yuen Tong Medicine Holdings Limited

Duration

Period

Chart Wai Yuen Tong Medicine Holdings Limited

More charts

Company Profile

Wai Yuen Tong Medicine Holdings Limited is a Hong Kong-based investment holding company principally engaged in the production and sales of pharmaceutical products. The Company operates through three segments. Production and Sale of Chinese Pharmaceutical and Health Food Products segment is mainly engaged in the manufacture, processing and retailing of traditional Chinese medicine in China and Hong Kong. Its products include Chinese medicines under the brand Wai Yuen Tong, as well as products manufactured with traditional prescriptions. Production and Sale of Western Pharmaceutical and Health Food Products segment is engaged in the processing and sales of Western pharmaceutical products and personal care products under the brands Madame Pearlâs and Pearlâs. Property Investment segment is engaged in the investment in commercial properties for rental income.

Sector

Pharmaceuticals

Calendar

2024-11-20 - Q2 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Alternative Medicine

	1st Jan change	Capi.
WAI YUEN TONG MEDICINE HOLDINGS LIMITED	-17.50%	47.55M
DONG-E-E-JIAO CO.,LTD.	+26.93%	5.55B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-33.55%	3.52B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	-3.74%	3.03B
TASLY PHARMACEUTICAL GROUP CO., LTD	-26.09%	2.59B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-10.93%	2.28B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+41.50%	1.88B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD	+41.84%	1.46B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-12.94%	1.43B
PT INDUSTRI JAMU DAN FARMASI SIDO MUNCUL TBK	+47.62%	1.42B